References
- I Kudo, and M Murakami. (2002). Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 68–69:3–58.
- CN Serhan, JZ Haeggström, and CC Leslie. (1996). Lipid mediator networks in cell signaling: Update and impact of cytokines. FASEB J 10:1147–1158.
- S Connolly, and DH Robinson. (1995). The search for inhibitors of the phospholipases A2. Expert Opin Ther Pat 5:673–683.
- JD Clark, and S Tam. (2004). Potential therapeutic uses of phospholipase A2 inhibitors. Expert Opin Ther Pat 14:937–950.
- M Lehr. (2006). Inhibitors of phospholipase A2α as potential anti-inflammatory drugs. Anti-Inflammatory Anti-Allergy Agents Med Chem 5:149–161.
- K Seno, T Okuno, K Nishi, Y Murakami, F Watanabe, T Matsuura, M Wada, Y Fujii, M Yamada, T Ogawa, T Okada, H Hashizume, M Kii, S Hara, S Hagishita, S Nakamoto, K Yamada, Y Chikazawa, M Ueno, I Teshirogi, T Ono, and M Ohtani. (2000). Pyrrolidine inhibitors of human cytosolic phospholipase A2. J Med Chem 43:1041–1044.
- S Connolly, C Bennion, S Botterell, PJ Croshaw, C Hallam, K Hardy, P Hartopp, CG Jackson, SJ King, L Lawrence, A Mete, D Murray, DH Robinson, GM Smith, L Stein, I Walters, E Wells, and WJ Withnall. (2002). Design and synthesis of a novel and potent series of inhibitors of cytosolic phospholipase A2 based on a 1,3-disubstituted propan-2-one skeleton. J Med Chem 45:1348–1362.
- R Rips, and NP Buu-Hoi. (1959). Aldehydes derived from 1,2,5-trisubstituted pyrroles. J Org Chem 24:372–374.
- K Seno, T Okuno, K Nishi, Y Murakami, K Yamada, S Nakamoto, and T Ono. (2001). Pyrrolidine inhibitors of human cytosolic phospholipase A2 part 2: Synthesis of potent and crystallized 4-triphenylmethylthio derivative “pyrrophenone”. Bioorg Med Chem Lett 11:587–590.
- M Schmitt, and M Lehr. (2004). HPLC assay with UV spectrometric detection for the evaluation of inhibitors of cytosolic phospholipase A2. J Pharm Biomed Anal 35:135–142.
- F Ghomashchi, R Loo, J Balsinde, F Bartoli, R Apitz-Castro, JD Clark, EA Dennis, and MH Gelb. (1999). Trifluoromethyl ketones and methyl fluorophosphonates as inhibitors of group IV and VI phospholipases A2: Structure-function studies with vesicle, micelle, and membrane assays. Biochim Biophys Acta 1420:45–56.
- M Lehr, and A Schulze Elfringhoff. (2000). Comparison of the inhibition of the cytosolic phospholipase A2-mediated arachidonic acid release by several indole-2-carboxylic acids and 3-(pyrrol-2-yl)propionic acids in bovine and in human platelets. Arch Pharm Pharm Med Chem 333:312–314.
- M Lehr, and K Griessbach. (1999). Cell lytic and cPLA2-inhibitory properties in bovine platelets of the commercially available cPLA2 inhibitors, arachidonyltrifluoromethyl ketone, methyl arachidonylfluorophosphonate and palmityltrifluoromethyl ketone. Pharm Pharmacol Commun 5:389–393.
- A Haller, and A Guyot. (1901). Investigations on the tautomerism of o-benzoylbenzoic acid. Bull Soc Chim Paris 25:49–56.
- W Graf, E Girod, E Schmid, and WG Stoll. (1959). The structure of benzophenone-2-carboxylic acid derivatives. Helv Chim Acta 42:1085–1101.
- DM Knauss, and JT Bender. (2002). Phthalide as an activating group for the synthesis of poly(aryl ether phthalide)s by nucleophilic aromatic substitution. J Polym Sci Part A: Polym Chem 40:3046–3054.
- JC McKew, MA Foley, P Thakker, ML Behnke, FE Lovering, FW Sum, S Tam, K Wu, MW Shen, W Zhang, M Gonzalez, S Liu, A Mahadevan, H Sard, SP Khor, and JD Clark. (2006). Inhibition of cytosolic phospholipase A2α: hit to lead optimization. J Med Chem 49:135–158.
- A Ghasemi, A Schulze Elfringhoff, and M Lehr. (2005). Structure–activity relationship studies of 3-dodecanoylindole-2-carboxylic acid inhibitors of cytosolic phospholipase A2α-mediated arachidonic acid release in intact platelets: variation of the keto moiety. J Enz Inhib Med Chem 20:429–437.